A Comparison Study on the Clinical Effects of Foscarnet Sodium Injection and Interferon on Human Immunodeficiency Virus-infected Patients Complicated with Herpes Zoster

Overview

Journal Pak J Med Sci

Specialty General Medicine

Date 2015 Jun 24

PMID 26101481

Citations 1

Authors

Yuan Yuan-Qu

Ming Xiong-Pu

Jing Xiao-Kang

Xia Cai-An

Affiliations

Soon will be listed here.

Abstract

Objective: To compare the clinical effects of foscarnet sodium injection and interferon on human immunodeficiency virus (HIV)-infected patients complicated with herpes zoster.

Methods: Ninety HIV-infected patients complicated with herpes zoster were divided into a treatment group and a control group that were both treated routinely first. Then the control group and treatment group were administered with interferon and foscarnet sodium injection respectively for four consecutive weeks.

Results: After four weeks, the effective rates of the treatment and control groups were 95.6% and 80.0% respectively, which were significantly different (P < 0.05). The pain scores of the two groups were similar before treatment, but the scores of the treatment group were significantly lower than those of the control group two and four weeks after treatment (P < 0.05) as well as were significantly lower than those before treatment (P < 0.05). The numbers of CD4+ cells and the contents of IL-2 of both groups two and four weeks after treatment significantly exceeded those before treatment (P < 0.05), with significant inter-group differences also (P < 0.05). Two and four weeks after treatment, the treatment group scored significantly higher in physical activity, energy, sleep, social life and emotional reaction than the control group did (P < 0.05).

Conclusions: HIV-infected patients are prone to being complicated with herpes zoster. Compared with interferon, foscarnet sodium injection better improves the clinical outcomes by effectively relieving pain and by regulating immune mediated inflammatory diseases, thus boosting the prognostic quality of life.

Citing Articles

Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: A case report.

Giannetta E, Isidori A, Durante C, Di Gioia C, Longo F, Tombolini V Medicine (Baltimore). 2017; 96(6):e5621.

PMID: 28178124 PMC: 5312981. DOI: 10.1097/MD.0000000000005621.

References

Seang S, Boutolleau D, Burrel S, Regnier S, Epelboin L, Voujon D . Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection. Int J STD AIDS. 2014; 25(9):676-82. DOI: 10.1177/0956462413518034. View

Herold B, Dezzutti C, Richardson B, Marrazzo J, Mesquita P, Carpenter C . Antiviral activity of genital tract secretions after oral or topical tenofovir pre-exposure prophylaxis for HIV-1. J Acquir Immune Defic Syndr. 2014; 66(1):65-73. PMC: 3981887. DOI: 10.1097/QAI.0000000000000110. View

Todesco E, Sayon S, Fourati S, Tubiana R, Simon A, Ktorza N . Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies. J Antimicrob Chemother. 2013; 68(12):2882-9. DOI: 10.1093/jac/dkt272. View

Drannik A, Nag K, Sallenave J, Rosenthal K . Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes. J Virol. 2013; 87(13):7526-38. PMC: 3700282. DOI: 10.1128/JVI.02243-12. View

Finn K, Ginns L, Robbins G, Wu C, Branda J . Case records of the Massachusetts General Hospital. Case 20-2014. A 65-year-old man with dyspnea and progressively worsening lung disease. N Engl J Med. 2014; 370(26):2521-30. DOI: 10.1056/NEJMcpc1400841. View

Shahapur P, Bidri R . Recent trends in the spectrum of opportunistic infections in human immunodeficiency virus infected individuals on antiretroviral therapy in South India. J Nat Sci Biol Med. 2014; 5(2):392-6. PMC: 4121922. DOI: 10.4103/0976-9668.136200. View

Piret J, Boivin G . Antiviral drug resistance in herpesviruses other than cytomegalovirus. Rev Med Virol. 2014; 24(3):186-218. DOI: 10.1002/rmv.1787. View

Schaftenaar E, Verjans G, Getu S, McIntyre J, Struthers H, Osterhaus A . High seroprevalence of human herpesviruses in HIV-infected individuals attending primary healthcare facilities in rural South Africa. PLoS One. 2014; 9(6):e99243. PMC: 4051661. DOI: 10.1371/journal.pone.0099243. View

Ehteshami M, Nijhuis M, Bernatchez J, Ablenas C, McCormick S, De Jong D . Formation of a quaternary complex of HIV-1 reverse transcriptase with a nucleotide-competing inhibitor and its ATP enhancer. J Biol Chem. 2013; 288(24):17336-46. PMC: 3682535. DOI: 10.1074/jbc.M112.433441. View

10.

Siddiqi O, Ghebremichael M, Dang X, Atadzhanov M, Kaonga P, Khoury M . Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults. Clin Infect Dis. 2014; 58(12):1771-7. PMC: 4036687. DOI: 10.1093/cid/ciu191. View

11.

Nixon B, Fakioglu E, Stefanidou M, Wang Y, Dutta M, Goldstein H . Genital herpes simplex virus type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease. J Infect Dis. 2013; 209(4):510-22. PMC: 3903370. DOI: 10.1093/infdis/jit472. View

12.

Akinboro A, Onayemi O, Mejiuni A . Frequency, pattern, and extent of skin diseases in relation to CD4+ cell count among adults with human immunodeficiency virus infection or acquired immunodeficiency syndrome in Osogbo, southwestern Nigeria. Int J Dermatol. 2014; 53(4):416-24. DOI: 10.1111/j.1365-4632.2012.05820.x. View

13.

Thompson M, Sharma S, Atianand M, Jensen S, Carpenter S, Knipe D . Interferon γ-inducible protein (IFI) 16 transcriptionally regulates type i interferons and other interferon-stimulated genes and controls the interferon response to both DNA and RNA viruses. J Biol Chem. 2014; 289(34):23568-81. PMC: 4156042. DOI: 10.1074/jbc.M114.554147. View

14.

Benova A, Brichova M, Svozilkova P, Kousal B, Jenickova D, Heissigerova J . [Cytomegalovirus retinitis in HIV negative patients - retrospective study]. Cesk Slov Oftalmol. 2014; 69(6):227-34. View

15.

Fox J, Shaw F . Relationship of income and health care coverage to receipt of recommended clinical preventive services by adults - United States, 2011-2012. MMWR Morb Mortal Wkly Rep. 2014; 63(31):666-70. PMC: 4584657. View

16.

Sabouri Ghannad M, Solgi G, Hashemi S, Zebarjady-Bagherpour J, Hemmatzadeh A, Hajilooi M . Herpes simplex virus encephalitis in hamadan, iran. Iran J Microbiol. 2014; 5(3):272-7. PMC: 3895567. View

17.

Leporrier J, Etienne M, Chapuzet C, Peytavin G, Bord S, Borsa-Lebas F . Association of dolutegravir and rilpivirine, enhanced by foscarnet induction, in effective salvage antiretroviral therapy. J Clin Virol. 2014; 60(4):428-30. DOI: 10.1016/j.jcv.2014.05.004. View

18.

Aissani B, Wiener H, Zhang K, Kaslow R, Ogwaro K, Shrestha S . A candidate gene approach for virally induced cancer with application to HIV-related Kaposi's sarcoma. Int J Cancer. 2013; 134(2):397-404. PMC: 4007164. DOI: 10.1002/ijc.28351. View